Author

Ji-Yuan Ding

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Severe cutaneous adverse reaction to aumolertinib plus vebreltinib in an EGFR-mutant NSCLC patient: a case report

The combination of aumolertinib and vebreltinib has emerged as an effective therapeutic strategy for advanced non-small cell lung cancer(NSCLC) harboring EGFR mutations with concurrent MET amplification. However, the safety profile of this combination regimen remains incompletely characterized, particularly with re...

Yao-Yao Zhang, Lu-Xing Zhang, Ji-Yuan Ding · Frontiers in Oncology · 0 citations

Open access Sep 2026

Phase I Evaluation of Siltartoxatug, a First‐in‐Class Anti‐Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations

Siltartoxatug, a first‐in‐class monoclonal antibody targeting tetanus toxin for post‐exposure prophylaxis, was evaluated in two phase I trials in Australian and Chinese healthy adults. In these randomized, double‐blind, placebo‐controlled, dose‐escalation studies, participants received a single intramuscular injection...

Xin-Yu Liu, Zhi-Gang Liu, Xiao-Hu Kuang et al. · Clinical pharmacology and th... · 0 citations